GlassScriptPhysician profile
Frederick R Lemley
NPI 1194760488
$5,045.18
in general payments reported to CMS, 2019-2025
14 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $318 · 2021: $203 · 2022: $319 · 2023: $1,350 · 2024: $737 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,193 · Education: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,193.31 |
| Education | $564.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,690.75 | 2019-2025 | Inbone, Infinity, Infinity Adaptis |
| Smith+Nephew, INC. | $1,065.49 | 2019-2025 | Trigen Intertan, Panta 2, Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $1,062.53 | 2019-2025 | Hammerlock, Fibulink, Lcp |
| Treace Medical Concepts, INC. | $413.05 | 2023-2025 | |
| Miach Orthopaedics, INC. | $291.96 | 2025 | |
| Exactech, INC. | $123.73 | 2020 | |
| Linvatec Corporation | $116.96 | 2019 | |
| Wright Medical Technology, INC. | $116.75 | 2019 | |
| Medline Industries LP | $76.40 | 2021 | |
| Aesculap, INC. | $24.45 | 2024 | Elan 4 |
| Mimedx Group, INC. | $19.82 | 2024 | |
| Abbvie INC. | $18.05 | 2023 | |
| Aroa Biosurgery Incorporated | $12.87 | 2019 | |
| Osteocentric Technologies, INC. | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Lemley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.